Inactive Instrument

Other languages Nexus BioPharma, Inc. Other OTC

Equities

Nexus BioPharma, Inc. Appoints Robert J. Neborsky, M.D. to Its Scientific and Clinical Advisory Board	10/17/10
Nexus BioPharma, Inc. Auditor Raises 'Going Concern' Doubt	06/17/06
Nexus BioPharma, Inc. announced that it has received $0.45 million in funding from JMJ Financial	08/17/08
Nexus BioPharma, Inc. to License TransChem's Transition State Chemistry Technology for Kinase Inhibition	10/16/10
Nexus BioPharma : Announces Agreement with TransChem for Kinase Inhibition Technology	07/16/07
Nexus Seeks Acquisition	28/16/28
Nexus BioPharma, Inc. : Appoints Helen Stefanovic as Director of Regulatory Affairs	22/16/22
Nexus BioPharma, Inc. Appoints Helen Stefanovic as Director of Regulatory Affairs	22/16/22
Nexus BioPharma, Inc. Auditor Raises 'Going Concern' Doubt	02/16/02
Nexus BioPharma Corporation completed the acquisition of Nexus BioPharma, Inc. in a reverse merger transaction.	09/16/09
Nexus BioPharma Corporation entered into an agreement of merger and plan of reorganization to acquire Nexus BioPharma, Inc. in a reverse merger transaction.	19/16/19

No results for this search